John R Vane1. Show Affiliations » 1. William Harvey Research Institute, St. Bartholomew's Hospital Medical College, London EC1M 6BQ, UK.
Abstract
Entities: Chemical
Mesh: See more » AnimalsAnti-Inflammatory Agents, Non-Steroidal/adverse effectsAnti-Inflammatory Agents, Non-Steroidal/therapeutic useCarotid Artery Injuries/pathologyCell DivisionClinical Trials as TopicCyclooxygenase 1Cyclooxygenase 2Cyclooxygenase 2 InhibitorsCyclooxygenase Inhibitors/adverse effectsCyclooxygenase Inhibitors/pharmacologyCyclooxygenase Inhibitors/therapeutic useEpoprostenol/metabolismHomeostasisHumansIsoenzymes/antagonists & inhibitorsLactones/adverse effectsLactones/pharmacologyLactones/therapeutic useMembrane ProteinsMiceMuscle, Smooth, Vascular/cytologyMyocardial Infarction/epidemiologyNaproxen/therapeutic usePlatelet Activation/drug effectsProstaglandin-Endoperoxide SynthasesReceptors, EpoprostenolReceptors, Prostaglandin/geneticsReceptors, Prostaglandin/metabolismReceptors, Thromboxane/geneticsReceptors, Thromboxane/metabolismSulfonesThromboxane A2/metabolism
Substances: See more » Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase 2 InhibitorsCyclooxygenase InhibitorsIsoenzymesLactonesMembrane ProteinsReceptors, EpoprostenolReceptors, ProstaglandinReceptors, ThromboxaneSulfonesrofecoxibThromboxane A2NaproxenEpoprostenolCyclooxygenase 1Cyclooxygenase 2PTGS1 protein, humanPTGS2 protein, humanProstaglandin-Endoperoxide SynthasesPtgs1 protein, mouse
Year: 2002 PMID: 11964462 DOI: 10.1126/science.1071702
Source DB: PubMed Journal: Science ISSN: 0036-8075 Impact factor: 47.728